Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic

Rabies virus (RV) vaccine strain-based vectors show great promise as vaccines against other viral diseases such as human immunodeficiency virus type 1 (HIV-1) infection and hepatitis C, but a low residual pathogenicity remains a concern for their use. Here we describe several highly attenuated secon...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	J Virol
المؤلفون الرئيسيون:	McGettigan, James P., Pomerantz, Roger J., Siler, Catherine A., McKenna, Philip M., Foley, Heather D., Dietzschold, B., Schnell, Matthias J.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 2003
الموضوعات:	Vaccines and Antiviral Agents
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140592/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12477829/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.1.237-244.2003
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!